Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 198
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance...
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations...
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today
BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics...
Entheon Biomedical Corp. Files Preliminary Shelf Prospectus
Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy...
MindMed Enrolls First Participant in a Study of its Session Monitoring...
PT285 – Andrew Penn, NP – The Need for Nurses in...
Psychedelic Research Bulletin: December 2021
Nova Mentis Provides Corporate Update – 2022 Planned Catalysts
Load more